Raymond James & Associates’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$344K Sell
32,809
-4,416
-12% -$46.3K ﹤0.01% 3309
2024
Q2
$436K Sell
37,225
-17,924
-33% -$210K ﹤0.01% 3127
2024
Q1
$1.16M Buy
55,149
+4,612
+9% +$97.2K ﹤0.01% 2491
2023
Q4
$907K Sell
50,537
-50,083
-50% -$899K ﹤0.01% 2563
2023
Q3
$1.66M Buy
100,620
+80,706
+405% +$1.33M ﹤0.01% 2122
2023
Q2
$398K Buy
19,914
+3,083
+18% +$61.6K ﹤0.01% 3052
2023
Q1
$318K Buy
16,831
+3,130
+23% +$59.2K ﹤0.01% 3175
2022
Q4
$311K Buy
13,701
+4,898
+56% +$111K ﹤0.01% 3176
2022
Q3
$233K Sell
8,803
-11,880
-57% -$314K ﹤0.01% 3325
2022
Q2
$511K Buy
20,683
+3,100
+18% +$76.6K ﹤0.01% 2890
2022
Q1
$584K Sell
17,583
-3,240
-16% -$108K ﹤0.01% 2959
2021
Q4
$681K Sell
20,823
-9,894
-32% -$324K ﹤0.01% 2867
2021
Q3
$1.29M Sell
30,717
-15,444
-33% -$648K ﹤0.01% 2406
2021
Q2
$1.79M Buy
46,161
+1,721
+4% +$66.8K ﹤0.01% 2167
2021
Q1
$1.52M Buy
44,440
+19,625
+79% +$669K ﹤0.01% 2212
2020
Q4
$1.13M Sell
24,815
-2,055
-8% -$93.2K ﹤0.01% 2255
2020
Q3
$739K Sell
26,870
-1,435
-5% -$39.5K ﹤0.01% 2357
2020
Q2
$1.04M Buy
28,305
+2,494
+10% +$91.8K ﹤0.01% 2131
2020
Q1
$836K Sell
25,811
-1,960
-7% -$63.5K ﹤0.01% 2099
2019
Q4
$1.14M Sell
27,771
-1,593
-5% -$65.3K ﹤0.01% 2190
2019
Q3
$1.05M Buy
29,364
+2,349
+9% +$83.6K ﹤0.01% 2181
2019
Q2
$1.39M Sell
27,015
-10,937
-29% -$562K ﹤0.01% 2020
2019
Q1
$2.18M Buy
37,952
+20,664
+120% +$1.18M ﹤0.01% 1708
2018
Q4
$725K Sell
17,288
-950
-5% -$39.8K ﹤0.01% 2294
2018
Q3
$1.38M Sell
18,238
-4,255
-19% -$321K ﹤0.01% 2037
2018
Q2
$1.61M Buy
+22,493
New +$1.61M ﹤0.01% 1902